共 65 条
Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer
被引:164
作者:
Dong, C.
[1
,2
]
Wu, Y.
[2
,3
]
Wang, Y.
[1
,2
]
Wang, C.
[2
,4
]
Kang, T.
[5
]
Rychahou, P. G.
[2
,6
]
Chi, Y-I
[1
]
Evers, B. M.
[1
,2
,6
]
Zhou, B. P.
[1
,2
]
机构:
[1] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA
[2] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40506 USA
[3] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40506 USA
[4] Univ Kentucky, Coll Med, Dept Biostat, Lexington, KY 40506 USA
[5] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[6] Univ Kentucky, Coll Med, Dept Surg, Lexington, KY 40506 USA
来源:
关键词:
metastasis;
EMT;
chromatin modifications;
transcription;
Snail;
EPITHELIAL-MESENCHYMAL TRANSITION;
NF-KAPPA-B;
HISTONE H3;
DNA METHYLATION;
GENE-EXPRESSION;
G9A;
METHYLTRANSFERASES;
DOMAIN;
INFLAMMATION;
SUPERFAMILY;
D O I:
10.1038/onc.2012.169
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Expression of E-cadherin, a hallmark of epithelial-mesenchymal transition (EMT), is often lost due to promoter DNA methylation in basal-like breast cancer (BLBC), which contributes to the metastatic advantage of this disease; however, the underlying mechanism remains unclear. Here, we identified that Snail interacted with Suv39H1 (suppressor of variegation 3-9 homolog 1), a major methyltransferase responsible for H3K9me3 that intimately links to DNA methylation. We demonstrated that the SNAG domain of Snail and the SET domain of Suv39H1 were required for their mutual interactions. We found that H3K9me3 and DNA methylation on the E-cadherin promoter were higher in BLBC cell lines. We showed that Snail interacted with Suv39H1 and recruited it to the E-cadherin promoter for transcriptional repression. Knockdown of Suv39H1 restored E-cadherin expression by blocking H3K9me3 and DNA methylation and resulted in the inhibition of cell migration, invasion and metastasis of BLBC. Our study not only reveals a critical mechanism underlying the epigenetic regulation of EMT, but also paves a way for the development of new treatment strategies against this disease. Oncogene (2013) 32, 1351-1362; doi:10.1038/onc.2012.169; published online 7 May 2012
引用
收藏
页码:1351 / 1362
页数:12
相关论文